Hot Keywords

NANJING AILY BIOTECHNOLOGY CO.,LTD

Country:China (Mainland)

Year Established: Business type: Lab/Research institutions

Integral:

1. Introduction of Xeloda

Xeloda (Capecitabine) is a kind of white solid. With its CAS registry number 154361-50-9, this chemical has its IUPAC name of pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate. Xeloda has its Chemical Formula of C15H22FN3O6 and Molecular Weight of 359.3501, and it belongs to the product categories of Active Pharmaceutical Ingredients; Antineoplastic; Bases & Related Reagents; Intermediates & Fine Chemicals; Nucleotides; Pharmaceuticals. When comes to the Xeloda solubility, it is slightly soluble in water. Besides, it should be kept in the cool, dry and well-ventilated place, away from heat and direct light.

2. Physical and Chemical Properties of Xeloda        Xeloda chemical structure

1). Melting point: 110-121 °C
2). Surface Tension: 51.3 dyne/cm
3). Density: 1.49 g/cm
4). Polar Surface Area: 89.9 Å2
5). Index of Refraction: 1.6
6). Molar Refractivity: 82.32 cm3
7). Molar Volume: 240.5 cm3

3. Xeloda product and Xeloda usage

As one kind of white solid, Xeloda has its special usage in medicine. Xeloda (Capecitabine) could be applied as one prodrug, which is used to treat the metastatic breast and colorectal cancers. Capecitabine had been approved by FDA and has been one important orally-administered chemotherapeutic agent. For being one hot product in the pharmaceutic market, Xeloda has lots of leading producers in China. For example, Nanjing Aily Biotechnology Co.,Ltd. This company is one leading Xeloda product producer and exporter in chemical manufacturing and custom synthesis. If you need more Xeloda detailed information, you coiuld refer to this manufacturer.

Other products from this supplier

Indacaterol

Indacaterol (CAS No. 312753-06-3 ) is a novel, ultra-long-acting,β(2)-adrenoceptor agonist developed for Novartis for the once-daily treatment of asthma and chronic obstructive pulmonary disease(COPD).

lorcaserin approval

lorcaserin fda approval happens on June 27, 2012 by the FDA.

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View